Fluctuation of anti-Ro/SS-A antibody levels in patients with systemic lupus erythematosus and Sjogren's syndrome: A prospective study

Clinical and Experimental Rheumatology

Volumn 17, Issue 1, 1999, Pages 63-68

  Praprotnik, S ^a   Bozic, B ^a   Kveder, T ^a   Rozman, B ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Prospective study; Ro SS A antibodies; Sjogren's syndrome; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY;

ADULT; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; COUNTER IMMUNOELECTROPHORESIS; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; GENE CONTROL; HUMAN; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS;

ADOLESCENT; ADULT; ANTIBODIES, ANTINUCLEAR; AUTOANTIGENS; COUNTERIMMUNOELECTROPHORESIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOBLOTTING; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RIBONUCLEOPROTEINS; RNA, SMALL CYTOPLASMIC; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME; TIME FACTORS; VASCULITIS, ALLERGIC CUTANEOUS;

EID: 0032984338     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. REICHLIN M, SCOFIELD RH: SS-A (Ro) autoantibodies. In PETER JB and SHOENFELD Y (Eds.): Autoantibodies, Elsevier Science B.V. 1996: 783-8.
2. MADDISON PJ, MOGOVERO H, PROVOST TT, REICHLIN M: The clinical significance of autoantibodies to a soluble cytoplasmic antigen in systemic lupus erythematosus and other connective tissue disease. J Rheumatol 1979; 6: 189-95.
3. REICHLIN M, HARLEY JB: Antibodies to Ro (SS-A) and the heterogeneity of systemic lupus erythematosus. J Rheumatol 1987; 14 (Suppl.): 112-7.
4. REICHLIN M: Antibodies to ribonuclear proteins in systemic lupus erythematosus. Rheum Dis Clin North Am 1994; 20: 29-43.
5. ALEXANDER EL, ARNETT FC, PROVOST TT, STEVENS MB: Sjögren's syndrome: Association of anti Ro (SS-A) antibodies with vasculitis, hematologic abnormalities and serologic hyperactivity. Ann Intern Med 1983; 98: 155-9.
6. ALEXANDER EL, RANZENBACH MR, KUMAR AJ et al.: Anti-Ro (SS-A) autoantibodies in central nervous system disease associated with Sjögren's syndrome (CNS-SS): Clinical, neuroimaging and angiographic correlates. Neurology 1994; 44: 899-908.
7. REICHLIN M, BRUCATO A, FRANK MB et al.: Concentration of autoantibodies to native 60-kd Ro/SS-A and 52-kd Ro/SS-A in eluates from the heart of a child who died with congenital complete heart block. Arthritis Rheum 1994; 37: 1698-703.
8. MCCAULIFFE DP, YIN H, WANG L, LUCAS L: Autoimmune sera react with multiple epitopes on recombinant 52 and 60 kDa Ro (SS-A) proteins. J Rheumatol 1994; 21: 1073-1080.
9. BOZIC B, PRUIJN GJM, ROZMAN B, VAN VENROOIJ WJ: Sera from patients with rheumatic diseases recognize different epitope regions on the 52-kD Ro/SS-A protein. Clin Exp Immunol 1993; 94: 227-35.
10. HARLEY JB, REICHLIN M: Antibodies to Ro/ SS-A and La/SS-B. In WALLACE DJ & HAHN BH (Eds.): Dubois' Lupus Erythematosus. Lea & Febiger, Philadelphia 1993: 225-32.
11. TOPFER F, GORDON T, MCCLUSKEY J: Intra- and intermolecular spreading of autoimmunity involving the nuclear self-antigens La (SS-B) and Ro(SS-A). Proc Natl Acad Sci USA 1995; 92: 875-9.
12. TRAMPOSH HD, SMITH CD, SENECAL JL, ROTHFIELD N: A long-term longitudinal study of anticentromere antibodies. Arthritis Rheum 1984; 27: 121-4.
13. TAN EM: Antinuclear antibodies: Diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989; 44: 93-151.
14. SCOFIELD RH, HENRY WE, KURIEN BT, JAMES JA, HARLEY JB: Immunization with short peptides from the sequences of the systemic lupus erythematosus-associated 60-kDa Ro autoantigen results in anti-Ro ribonucleoprotein autoimmunity. J Immunol 1996; 156: 4059-66.
15. TAN EM, COHEN AS, FRIES JF et al.: The 1982 revised criteria for classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
16. FOX RI, ROBINSON CA, CURD JG, KOZIN F, HOWELL FV: Sjögren's syndrome: Proposed criteria for classification. Arthritis Rheum 1986; 29: 577-85.
17. VITALI C, BENCIVELLI W, ISENBERG DA et al.: Disease activity in systemic lupus erythematosus: Report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. Clin Exp Rheumatol 1992; 10: 541-7.
18. BUN CC, KVEDER T: Counterimmunoelectrophoresis and immunodiffusion for the detection of antibodies to soluble cellular antigens. In MAINI RN, VAN VENROOIJ WJ (Eds.): Manual of Biological Markers of Disease. Section A: Methods of Autoantibodies Detection, Dordrecht, Boston, London, Kluver Academic Publisher, 1993.
19. CLARK G, REICHLIN M, TOMASI TB: Characterisation of the soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus. J Immunol 1969; 102: 117-22.
20. BEN-CHETRIT E, CHAN EKL, SULLIVAN KF, TAN EM: A 52-kD protein is a novel component of the SS-A/Ro antigen particle. J Exp Med 1988; 167: 1560-71.
21. HABETS WJ, DE ROOIJ DJ, HOET MV, VAN DE PUTTE LB, VAN VENROOIJ WJ: Quantitation of anti-RNP and anti-Sm antibodies in MCTD and SLE patients by immunoblotting. Clin Exp Immunol 1985; 59: 457-66.
22. PRUIJN GMJ, BOZIC B, SHOUTE F, ROKEACH LA, VAN VENROOIJ WJ: Refined definition of the 56K and other autoantigens in the 50-60 kDa region. Mol Biol Reports 1992; 16: 267-76.
23. BUYON JP, SLADE SG, CHAN EKL, TAN EM WINCHESTER R: Effective separation of the 52kDa SSA/Ro polypeptide from the 48 kDa SSB/La polypeptide by altering conditions of polyacrylamide gel electrophoresis. J Immunol Methods 1990; 129: 207-10.
24. MADDISON PJ, REICHLIN M: Deposition of antibodies to a soluble cytoplasmic antigen in the kidney of patients with systemic lupus erythematosus. Arthritis Rheum 1979; 22: 8.
25. PENNER E, REICHLIN M: Primary biliary cirrhosis associated with Sjögren's syndrome: evidence for circulating and tissue deposited Ro/anti-Ro immune complexes. Arthritis Rheum 1982; 25: 1250-53.
26. ALEXANDER E, BUYON JP, PROVOST TT, GAURNERI T: Anti Ro/SS-A antibodies in the pathophysiology of congenital heart block in neonatal lupus syndrome, an experimental model. In vitro electrophysiology and immunocytochemical studies. Arthritis Rheum 1992; 35: 176-89.
27. NIIMI Y, JOANNIDES D, BUYON J, BYSTRYN JC: Heterogeneity in the expression of Ro and La antigens in human skin. Arthritis Rheum 1995; 38: 1271-6.
28. SCOPELITIS E, BIUNDO JJ, ALSPAUGH MA: Anti SS-A antibody in systemic lupus erythematosus. Arthritis Rheum 1980; 23: 287-93.
29. VAN VENROOIJ WJ, CHARELS P, MAINI RN: The consensus workshop for the detection of autoantibodies to intracellular antigens in rheumatic diseases. J Immunol Meth 1991; 140: 181-9.
30. MCCAULIFFE DP: Cutaneous diseases in adults associated with anti-Ro/SS-A autoantibody production. Lupus 1997; 6: 158-66.
31. MARKUSSE HM, SCHOONBROOD M, OUDKEREK M, HENZEN-LOGMANS SC: Leukocytoclastic vasculitis as a presenting feature of primary Sjögren's syndrome. Clin Rheumatol 1994; 13: 269-72.
32. ALEXANDER EL, PROVOST TT: Cutaneous manifestations of primary Sjögren's syndrome: A reflection of vasculitis and association with anti-Ro(SS/-A) antibodies. J Invest Dermatol 1983; 80: 386-91.
33. PROVOST TT et al.: The relationship between anti-Ro (SS-A) antibody-positive Sjögren's syndrome and anti-Ro (SS-A) antibody-positive lupus erythematosus. Arch Dermatol 1988; 124: 63-71.
34. PROVOST TT, VASILY D, ALEXANDER E: Sjögren's syndrome. Cutaneous, immunologic, and nervous system manifestations. Neurol Clin 1987; 5: 405-26.
35. TSENG C-E, DI DONATO F, BUYON JP: Stability of immunoblot profile of anti-SSA/Ro-SSB/La antibodies over time in mothers whose children have neonatal lupus. Lupus 1996; 5: 212-5.
36. RICCHIUTI V, ISENBERG D, MULLER S: HLA association of anti-Ro60 and anti-Ro52 antibodies in Sjögren's syndrome. J Autoimmunity 1994; 7: 611-21.